These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 20237505

  • 1. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.
    Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
    [Abstract] [Full Text] [Related]

  • 2. The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
    Montano G, Ullmark T, Jernmark-Nilsson H, Sodaro G, Drott K, Costanzo P, Vidovic K, Gullberg U.
    Leuk Res; 2016 Jan; 40():60-7. PubMed ID: 26563595
    [Abstract] [Full Text] [Related]

  • 3. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E.
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [Abstract] [Full Text] [Related]

  • 4. Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
    Vidovic K, Ullmark T, Rosberg B, Lennartsson A, Olofsson T, Nilsson B, Gullberg U.
    Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
    [Abstract] [Full Text] [Related]

  • 5. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM, Hagen P, Hussels CS, Ballmaier M, Scholz H, Dame C.
    FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Aug; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 7. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.
    Krug U, Yasmeen A, Beger C, Bäumer N, Dugas M, Berdel WE, Müller-Tidow C.
    Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
    Maurer U, Brieger J, Weidmann E, Mitrou PS, Hoelzer D, Bergmann L.
    Exp Hematol; 1997 Aug; 25(9):945-50. PubMed ID: 9257807
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
    Ortmann CA, Burchert A, Hölzle K, Nitsche A, Wittig B, Neubauer A, Schmidt M.
    Nucleic Acids Res; 2005 Aug; 33(21):6895-905. PubMed ID: 16396836
    [Abstract] [Full Text] [Related]

  • 12. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N, Shirakata T, Nishida S, Yanagihara M, Tsuboi A, Kawakami M, Oji Y, Oka Y, Okabe M, Tan B, Sugiyama H, Weissman IL.
    Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
    [Abstract] [Full Text] [Related]

  • 13. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
    Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, Vinante F, Tecchio C, Piras G, Gabbas A, Monne M, Sorio C.
    Cancer Res; 2010 Nov 01; 70(21):8896-906. PubMed ID: 20959494
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
    Breast Cancer Res; 2007 Nov 01; 9(4):R43. PubMed ID: 17634147
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M, Lee SJ, Alam R, Coombes K, Huff V.
    Oncogene; 2003 Jun 12; 22(24):3821-6. PubMed ID: 12802290
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
    Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, Bornstein P, Binétruy B, Cabon F.
    Oncogene; 1999 May 20; 18(20):3143-51. PubMed ID: 10340386
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
    Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, Chan AT, Sung JJ, Tao Q.
    Oncogene; 2008 Sep 04; 27(39):5267-76. PubMed ID: 18469857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.